Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (Q1654244): Difference between revisions

@@ Property / describes a project that uses @@
+Cubature
@@ Property / describes a project that uses: Cubature / rank @@
+Normal rank
@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / OpenAlex ID @@
+W2590308184
@@ Property / OpenAlex ID: W2590308184 / rank @@
+Normal rank
@@ Property / cites work @@
+Q3997739
@@ Property / cites work: Q3997739 / rank @@
+Normal rank
@@ Property / cites work @@
+Q3445852
@@ Property / cites work: Q3445852 / rank @@
+Normal rank
@@ Property / cites work @@
+Adaptive designs for dose-finding based on efficacy-toxicity response
+Normal rank
@@ Property / cites work @@
+Model-oriented design of experiments
@@ Property / cites work: Model-oriented design of experiments / rank @@
+Normal rank
@@ Property / cites work @@
+Dose finding in drug development.
@@ Property / cites work: Dose finding in drug development. / rank @@
+Normal rank
@@ Property / cites work @@
+Q4699452
@@ Property / cites work: Q4699452 / rank @@
+Normal rank
@@ Property / cites work @@
+Optimal design in random-effects regression models
+Normal rank
@@ Property / cites work @@
+Mixed-Effects Models in S and S-PLUS
@@ Property / cites work: Mixed-Effects Models in S and S-PLUS / rank @@
+Normal rank
@@ Property / cites work @@
+Dose-Finding Based on Efficacy-Toxicity Trade-Offs
+Normal rank
@@ Property / cites work @@
+Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
+Normal rank
@@ Property / cites work @@
+A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler
+Normal rank
@@ Property / cites work @@
+Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
+Normal rank